Previous Close | 38.97 |
Open | 38.92 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 38.80 - 39.51 |
52 Week Range | 38.80 - 39.51 |
Volume | |
Avg. Volume | N/A |
Market Cap | N/A |
Beta (5Y Monthly) | 0.60 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Jul 25, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 46.48 |
Prestigious International Program Recognizes Standout Digital Health & Medical Technology Products and CompaniesLOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market, today announced that Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has been sele
Press ReleaseVELIZY-VILLACOUBLAY, France — May 3, 2024 COMBINED GENERAL SHAREHOLDERS’ MEETING OF MAY 22, 2024 Availability of preliminary documents Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) informs its shareholders that its Combined Shareholders’ Meeting will be held on Wednesday, May 22, 2024 at 3:00 pm at Dassault Systèmes’ headquarters, 10 rue Marcel Dassault – 78140 Vélizy-Villacoublay. The preliminary notification stating the agenda and the draft resolutions was published in
Press ReleaseVELIZY-VILLACOUBLAY, France — May 2, 2024 DISCLOSURE OF TRADING IN OWN SHARES(Repurchase program decided by the General Meeting of Shareholders of May 24, 2023) Issuer: Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA)Type of securities: Ordinary sharesPeriod: April 26, 2024 Detailed information (presentation by day and by market and transaction-by-transaction details) can be consulted on the website of Dassault Systèmes: https://investor.3ds.com/regulated-information/permane